BiOpTo: Tomgraphic phase micross for bidical applications (Q84172)

From EU Knowledge Graph
Revision as of 10:03, 4 March 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): The main of the project is to develop, test and formulated for commercialising (TRL7).TPM is working with projections appropriate within a limited angaroo range.The system of Computing and mapping provides full processing path:from digital acquisition of investment objective’s projections to 3D work.The TPM supplies suitable biomarkers for the treatment of osteothritis, cancer and cardiac diseases.In the course of the project, an initial busines...)
Jump to navigation Jump to search
Project in Poland financed by DG Regio
Language Label Description Also known as
English
BiOpTo: Tomgraphic phase micross for bidical applications
Project in Poland financed by DG Regio

    Statements

    0 references
    5,406,700.5 zloty
    0 references
    1,297,608.1199999999 Euro
    13 January 2020
    0 references
    5,406,700.5 zloty
    0 references
    1,297,608.1199999999 Euro
    13 January 2020
    0 references
    100.0 percent
    0 references
    1 November 2016
    0 references
    31 January 2022
    0 references
    POLITECHNIKA WARSZAWSKA
    0 references
    The main goal of the project is to develop, test and prepare for commercialization (TRL7) a novel tool for quantitative 3D analysis of phase biological microobjects namely the tomographic phase microscope (TPM). TPM is working with projections acquired within a limited angular range, which are captured sequentially or through an innovative system of parallel projections. The system of computational imaging provides full processing path: from digital acquisition of investigated object’s projections up to 3D visualization. The TPM supports such biomedical applications as histopathology, traceable measurement of cells and tissues, advanced therapy medicinal products for the treatment of osteoarthritis, cancer and cardiac diseases. In the course of the project, an initial business plan will be created in order to prepare the TPM for commercialization. (Polish)
    0 references
    The main of the project is to develop, test and formulated for commercialising (TRL7).TPM is working with projections appropriate within a limited angaroo range.The system of Computing and mapping provides full processing path:from digital acquisition of investment objective’s projections to 3D work.The TPM supplies suitable biomarkers for the treatment of osteothritis, cancer and cardiac diseases.In the course of the project, an initial business plan will be created in order to make the TPM for commercialisation. (English)
    0 references

    Identifiers

    POIR.04.04.00-00-1C1D/16
    0 references